Details for New Drug Application (NDA): 207047
✉ Email this page to a colleague
The generic ingredient in CLINDAMYCIN PALMITATE HYDROCHLORIDE is clindamycin palmitate hydrochloride. There are fifty-five drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the clindamycin palmitate hydrochloride profile page.
Summary for 207047
Tradename: | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
Applicant: | Heritage Pharms Inc |
Ingredient: | clindamycin palmitate hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 207047
Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Suppliers and Packaging for NDA: 207047
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLINDAMYCIN PALMITATE HYDROCHLORIDE | clindamycin palmitate hydrochloride | FOR SOLUTION;ORAL | 207047 | ANDA | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-603 | 23155-603-51 | 1 BOTTLE in 1 CARTON (23155-603-51) / 100 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SOLUTION;ORAL | Strength | EQ 75MG BASE/5ML | ||||
Approval Date: | May 11, 2018 | TE: | AA | RLD: | No |
Complete Access Available with Subscription